A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales: Wang, Yiyun, Yang, Yingying, Hong, Ruimin, Zhao, Houli, Wei, Guoqing, Wu, Wenjun, Xu, Huijun, Cui, Jiazhen, Zhang, Yanlei, Chang, Alex H., Hu, Yongxian, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572410/
https://www.ncbi.nlm.nih.gov/pubmed/33077713
http://dx.doi.org/10.1038/s41408-020-00371-6
Descripción
Sumario:

Ejemplares similares